相关实验视频
Updated: May 5, 2026

06:51
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
30.6K
PPARδ: 在胰腺管道腺癌中被低估的瘤加速器
Danping Niu1, Daoyan Wei2, Yi Liu1
1Department of Gastrointestinal Medical Oncology.
Cancer letters
|February 28, 2026
概括
过氧体增殖器激活受体三角 (PPARδ) 激活促进了从前体病变的胰腺癌进展. 向PPARδ可能为胰腺管腺癌 (PDAC) 提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 胰腺管腺癌 (PDAC) 是一种致命的癌症,由于晚期诊断和攻击性行为,其结果不佳.
- 胰腺内皮瘤 (PanIN) 是常见的前体,但很少发展为侵入性PDAC,这表明人们对过渡机制的理解不足.
研究的目的:
- 审查最近关于氧酶增殖器激活受体三角体 (PPARδ) 在KRAS突变胰腺瘤发生中的作用的进展.
- 突出PPARδ在PDAC进展过程中对代谢重编程和免疫抑制的参与.
主要方法:
- 对研究PPARδ在胰腺癌中的研究的文献综述.
- 对将PPARδ激活与KRAS驱动的PDAC联系起来的分子机制的分析.
主要成果:
- PPARδ激活与促进瘤性KRAS启动的胰腺瘤发生有关.
- PPARδ影响关键的癌症过程,包括代谢重编程和免疫抑制在PDAC.
结论:
- PPARδ在胰腺癌从前体病变的进展中发挥着重要作用.
- PPARδ成为治疗胰腺管道腺癌的有前途的治疗标.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

